Studies Reveal Ivermectin Greatly Reduces COVID Mortality

WASHINGTON, D.C. – A new study shows Ivermectin can reduce the chance of COVID death by 92 percent. The large prospective observational study of 88,012 people in a strictly controlled city-wide program in Southern Brazil, shows that regular use of Ivermectin as prophylaxis for COVID-19 led up to 92 percent reduction in COVID-19 mortality rate. In fact, there were 0 COVID hospitalizations in the group of regular Ivermectin users compared to 10 in the irregular user group. This exploratory analysis of a prospective observational study involved a program that used Ivermectin at a dose of 0.2mg/kg/day for two consecutive days, every 15 days. Data was gathered over a 150-day period. Regular users had 180mg or more of Ivermectin; irregular users had up to 60mg, in total, throughout the period of the program. Comparisons were made between non-users (subjects who did not use Ivermectin), regular and irregular users from the city of Itajaí after multivariate adjustments.